Acta Neurochirurgica

, Volume 155, Issue 6, pp 959–963 | Cite as

The impact of improved treatment strategies on overall survival in glioblastoma patients

  • P. J. Slotty
  • B. Siantidis
  • T. Beez
  • H. J. Steiger
  • M. Sabel
Clinical Article - Brain Tumors

Abstract

Background

The introduction of ALA-Fluorescence-guided surgery (FGS) followed by concomitant radiochemotherapy according to the Stupp-protocol is representative of the major changes in glioblastoma therapy in the past years. We were interested in the impact of this new first-line treatment on the overall survival of patients suffering from newly diagnosed primary glioblastoma in a retrospective single-centre study.

Method

For this retrospective analysis, data was derived from a prospective single-centre database. Patients were divided into three treatment groups: A (FGS−/radiochemotherapy−), B (FGS−/radiochemotherapy+) and C (FGS+/radiochemotherapy+). Further stratification was applied regarding MGMT-methylation status and degree of resection. Statistical analysis was performed to determine factors (treatment regime, age, gender, performance status, MGMT promoter methylation status) significantly influencing overall survival (OAS).

Results

Two hundred and fifty-three patients suffering from primary glioblastoma treated by cytoreductive surgery between 2002 and 2009 were included in this survey. Median OAS differed significantly between the treatment groups (A = 8.8, B = 16.6, C = 20.1, p < 0.01). Resection data was available in all 253 patients. The usage of FGS highly significantly correlated with a complete resection (p < 0.01). Complete resection was positively correlated with an increase in OAS (complete 20.3 months vs. incomplete 9.3 months, p < 0.01).

Conclusions

FGS and radiochemotherapy according to the Stupp protocol have induced an impressive improvement in overall survival in glioblastoma patients. This effect is not limited to clinical trials, but is reproducible in daily routine.

Keywords

Glioblastoma Fluorescence guided resection Temodal Overall survival 

Notes

Previous presentations

This survey has been presented in part in an oral presentation at the annual 2012 meeting of the German Society of Neurosurgery (DGNC)

Conflicts of interest

None.

References

  1. 1.
    Barker CA, Chang M, Chou JF, Zhang Z, Beal K, Gutin PH, Iwamoto FM (2012) Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. J Neurooncol 109:391–397PubMedCrossRefGoogle Scholar
  2. 2.
    Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, Berger MS, Parsa AT (2012) Impact of extent of resection for recurrent glioblastoma on overall survival. J Neurosurg 117:1032–1038PubMedCrossRefGoogle Scholar
  3. 3.
    Darefsky AS, King JT Jr, Dubrow R (2012) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer 118:2163–2172PubMedCrossRefGoogle Scholar
  4. 4.
    Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J (2010) Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States. Clin Cancer Res: Off J Am Assoc Cancer Res 16:2443–2449CrossRefGoogle Scholar
  5. 5.
    Johnson DR, O’Neill BP (2012) Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol 107:359–364PubMedCrossRefGoogle Scholar
  6. 6.
    Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro-Oncology 13:1339–1348PubMedCrossRefGoogle Scholar
  7. 7.
    Orringer D, Lau D, Khatri S, Zamora-Berridi GJ, Zhang K, Wu C, Chaudhary N, Sagher O (2012) Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival. J Neurosurg 117:851–859PubMedCrossRefGoogle Scholar
  8. 8.
    Raysi Dehcordi S, De Paulis D, Marzi S, Ricci A, Cimini A, Cifone MG, Galzio RJ (2012) Survival prognostic factors in patients with glioblastoma: our experience. J Neurosurg Sci 56:239–245PubMedGoogle Scholar
  9. 9.
    Saether CA, Torsteinsen M, Torp SH, Sundstrom S, Unsgard G, Solheim O (2012) Did survival improve after the implementation of intraoperative neuronavigation and 3D ultrasound in glioblastoma surgery? A retrospective analysis of 192 primary operations. J Neurol Surg Part A, Central Eur Neurosurg 73:73–78CrossRefGoogle Scholar
  10. 10.
    Senft C, Franz K, Blasel S, Oszvald A, Rathert J, Seifert V, Gasser T (2010) Influence of iMRI-guidance on the extent of resection and survival of patients with glioblastoma multiforme. Technol Cancer Res Treat 9:339–346PubMedGoogle Scholar
  11. 11.
    Shahar T, Nossek E, Steinberg DM, Rozovski U, Blumenthal DT, Bokstein F, Sitt R, Freedman S, Corn BW, Kanner AA, Ram Z (2012) The impact of enrollment in clinical trials on survival of patients with glioblastoma. J Clin Neurosci: Off J Neurosurg Soc Australas 19:1530–1534CrossRefGoogle Scholar
  12. 12.
    Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93:1003–1013PubMedCrossRefGoogle Scholar
  13. 13.
    Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S (2002) Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol: Off J Am Soc Clin Oncol 20:1375–1382CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • P. J. Slotty
    • 1
  • B. Siantidis
    • 1
  • T. Beez
    • 1
  • H. J. Steiger
    • 1
  • M. Sabel
    • 1
  1. 1.Neurochirurgische KlinikHeinrich-Heine-Universität DüsseldorfDüsseldorfGermany

Personalised recommendations